GPT and Hypoalbuminemia: Approximately 3 months after the last administration of T-DXd, upon completion of steroid tapering and with the reduction in liver enzymes (AST and ALT) to grade 1 and hypoalbuminemia to grade 0, the patient was offered to start treatment with carboplatin and trastuzumab every 21 days.